Abstract: A non-solvent curable composition including a quantum dot and a polymerizable monomer having a carbon-carbon double bond at the terminal end and having a vapor pressure of about 1×10?5 mmHg to about 1×10?4 mmHg, a cured layer manufactured utilizing the non-solvent curable composition, a color filter including the cured layer, a display device including the color filter, and a method of manufacturing the cured layer are disclosed.

Abstract: A control method of a fastening tool for fastening a component part includes photographing a fastening portion of the component part through a camera portion mounted on the fastening tool. The control method includes pre-processing that rotates an input image, which has been photographed by the camera portion, to match with representative model image. The control method includes estimating the fastening portion through an inference process through a convolutional neural network (CNN) algorithm-based image classification work on a video input image of a same fastening portion finished with the pre-processing work. The control method also includes setting a torque value that is matched with a recognized fastening portion when a probability value of the fastening portion in the inference process exceeds a predetermined reference ratio.

Abstract: The present invention relates to a coating composition for an in-vivo implantable prosthesis including a photoinitiator, a crosslinking agent, and a phosphorylcholine (pc) monomer having an acrylate group, a method of coating an in-vivo implantable prosthesis using the coating composition, and a cosmetic prosthesis coated with the crosslinked polyphosphorylcholine. An in-vivo implantable prosthesis coated with crosslinked polyphosphorylcholine may be manufactured by a simple method of applying a coating composition including a photoinitiator, a crosslinking agent, and a phosphorylcholine (pc) monomer having an acrylate group according to the present invention, and then irradiating uv rays. The crosslinked polyphosphorylcholine coating may provide hydrophilicity for the surface and may also remarkably reduce adsorption of proteins and fibroblasts, which may cause side effects such as capsular contracture.

Abstract: Disclosed are methods and apparatuses for transmitting data using a random access procedure in a communication system. An operation method of a terminal in a communication system includes transmitting a first MsgA including an RA preamble #i and a payload to a base station; receiving, from the base station, a MsgB including information indicating that an RA preamble #k is reserved; and transmitting a second MsgA including the RA preamble #k and data to the base station in a preamble reservation period associated with the RA preamble #k.

Abstract: A method for evaluating the risk of data leakage in an application includes the steps of: extracting a DEX (Dalvik Executable) file and a so (Shared Object) file by decompressing an APK file of a mobile application; extracting DEX code information from the DEX file by parsing the DEX file; translating a content of the so file into IR (Intermediate Representation); extracting IR code information from the translated IR; generating a call-reference structure between the DEX file and the so file by processing the extracted DEX code information and the extracted IR code information; and outputting weakness information according to a risk designated in advance based on the generated call-reference structure. Accordingly, it is possible to extend the call-reference coverage of an android application.

Abstract: A server according to an embodiment includes a processor configured to receive a friend add request for a target account from a user terminal accessed with a user account; based on one of the user account and the target account being a protected account, transmit an approval request for the friend add request to a protector account connected to the protected account; and based on receiving a reply to the approval request from the protector terminal, add the target account to a friend list of the user account.

Abstract: Provided is a stereoscopic surface display device including a stereoscopic display unit having a cell area, wherein the stereoscopic display unit includes a first flexible layer, a first optical waveguide and a first optical output unit in the first flexible layer, wherein the first optical output unit are disposed in the cell area, a first light source disposed on a side of the stereoscopic display unit, wherein the first optical waveguide connects the first light source and the first optical output unit, a first photothermal response layer on the first flexible layer, wherein the first photothermal response layer is configured to receive output light emitted from the first optical output unit and emit thermal energy, and a shape deformation layer on the first photothermal response layer, wherein the shape deformation layer is configured to generate bending deformation by receiving the thermal energy from the first photothermal response layer.

Abstract: A novel quinazoline compound having SOS1 inhibitory activity and uses of the quinazoline compound are disclosed. More particularly, the present invention relates to a novel quinazoline derivative compound having inhibitory activity on SOS1 binding to RAS family proteins and/or RAC1, to pharmacologically acceptable salts thereof, and to pharmaceutical compositions containing the quinazoline compound. The novel quinazoline compound has the following chemical formula 1: wherein all the variables have meaning as defined in the specification.

Abstract: Quantum dots surface-modified with a compound represented by Chemical Formula 1 or Chemical Formula 2, a curable composition including the quantum dots, a cured layer, and a color filter. In Chemical Formula 1 and Chemical Formula 2, each substituent is the same as defined in the specification.

Abstract: The present invention provides a Streptomyces sp. SNC087 strain (KCCM12505P) that is isolated from seawater and produces staurosporine, a method for producing staurosporine using the same, a method for culturing the same, and a pure culture medium of the same.

Abstract: A device for producing nanoparticles includes: a first connector comprising a first supply tube fitting member, a second supply tube fitting member, and a first discharge tube fitting member; a first tube having one side connected to the first supply tube fitting member; a second tube having one side connected to the second supply tube fitting member; a first conduit having one side connected to the first discharge tube fitting member; a first supply connected to another side of the first tube to supply a first material to the first conduit; and a second supply connected to another side of the second tube to supply a second material to the first conduit.

Abstract: A photosensitive resin composition includes: (A) a binder resin; (B) a photopolymerizable monomer; (C) a photopolymerization initiator; (D) a quantum dot surface-modified with a compound having a thiol group at one terminal end and an alkoxy group, a cycloalkyl group, a carboxyl group, or a hydroxy group at the other terminal end; and (E) a solvent. A curable composition includes: (A?) a resin; (B?) a quantum dot surface-modified with a compound represented by Chemical Formula 1 or Chemical Formula 2; and (C?) a solvent. A method of manufacturing the surface-modified quantum dot, and a color filter manufactured using the photosensitive resin composition or the curable composition are also disclosed.

Abstract: The provided is a hydrogel that utilizes the naturally occurring substance pectin to exhibit an equivalent or greater effect. Specifically, the present application is intended to provide a hydrogel or a patch which is stable, has strong adhesive strength, is advantageous for drug delivery, can be used for sustained treatment, has extremely low cytotoxicity, and is unlikely to induce an immune response, and thus can be used on various body parts, in particular the oral cavity. In addition, the provide is a hydrogel patch which employs a freeze-drying method prior to crosslinking, and thus exhibits superior adhesion to patches employing a post-crosslinking freeze-drying method.

Abstract: An apparatus performs a method for estimating residual stress of a material such as plastics. The apparatus includes an inspection unit configured to emit a terahertz wave to a subject to be inspected and to detect the terahertz wave transmitted through or reflected from the subject, and a controller configured to estimate residual stress of the subject based on the terahertz wave detected by the inspection unit.

Abstract: A non-solvent curable composition including a quantum dot and a polymerizable monomer having a carbon-carbon double bond at the terminal end and having a vapor pressure of about 1×10?5 mmHg to about 1×10?4 mmHg, a cured layer manufactured utilizing the non-solvent curable composition, a color filter including the cured layer, a display device including the color filter, and a method of manufacturing the cured layer are disclosed.

Abstract: One aspect provides a physiologically based pharmacokinetic core model which may be commonly applied to two or more compounds that share the same core structure, and a method of constructing the physiologically based pharmacokinetic core model. According to the physiologically based pharmacokinetic core model and the method of constructing the physiologically based pharmacokinetic core model, there is the effect of conducting exposure evaluation simply only by deriving a distribution coefficient, without constructing a separate PBPK model for each individual compound.

Abstract: Bladder systems for footwear uppers, footwear components (e.g., uppers), and articles of footwear including the bladder systems, and/or methods of making and using such bladder systems are described. The bladder systems may include two or more bladder pods engaged together by one or more elastic connectors. The elastic connector(s) may enable the bladder system to fit snugly around the wearer's ankle and/or heel area while still allowing some relative movement between the bladder pods, e.g., as a wearer moves in an article of footwear. In this manner, the bladder systems provide support and a snug fit and return to its/their original size, shape, and/or location once the force from the wearer's movement is removed or sufficiently relaxed. Additionally or alternatively, the bladder systems may provide impact force attenuation properties, e.g., to protect the wearer's ankle and/or heel.

Abstract: Bladders for footwear uppers, footwear components including the bladders, articles of footwear including the bladders, and/or methods of making and using such bladders are described. Such bladder systems may include two thermoplastic elastomer sheets joined together at an outer perimeter bond. The outer perimeter bond may be shaped such that the interior chamber of the bladder forms: (i) a foot support chamber portion for supporting at least a portion of a plantar surface of a wearer's foot and (ii) one or more side chamber portions forming at least part of one or more securing straps and/or at least part of one or more footwear upper components. The one or more side chamber portions extend outward from the foot support chamber portion and are in fluid communication with the foot support chamber portion.

Abstract: Bladders for footwear uppers, footwear components and articles of footwear including the bladders, and/or methods of making and using such bladders are described. The bladders may include first and second thermoplastic elastomer sheets joined together by an outer perimeter bond. An interior chamber is defined between the thermoplastic elastomer sheets and inside the outer perimeter bond. The outer perimeter bond may be shaped such that the interior chamber forms: (i) a foot support chamber portion for supporting at least a portion of a plantar surface of a wearer's foot, and at least one of items (ii) and (iii) below, in which: item (ii) comprises a first side chamber portion (e.g., forming at least part of a first securing strap or a first footwear upper component), and item (iii) comprises a second side chamber portion (e.g., forming at least part of a first strap-engaging member or a second footwear upper component).

Abstract: The present specification relates to a heterocyclic compound represented by Chemical Formula 1, and an organic light emitting device comprising the same.